Drug recall · December 9, 2015
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills recall
Why: Discoloration
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01
- Lots / codes
Lots R4016A (Exp 08/31/2015), R4017A (Exp 08/31/2015), R4035A (Exp 12/31/2015)
- Quantity
- 32,490 cartons
- Company
- Nephron Pharmaceuticals Corp., Orlando, FL
- Distribution
- Nationwide
- Initiated
- August 21, 2015 · Voluntary: Firm initiated
- Classified
- November 27, 2015
- Reported
- December 9, 2015
- Ended
- February 10, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Racepinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.